The prophylactic antithrombotic efficacy of a low molecular weight heparin was compared with a traditional unfractionated calcium heparin after orthopaedic surgery in 140 patients. Deep vein thromboses were detected in legs either by Doppler sonography or [125I]fibrinogen uptake tests in five (7.1%) and seven (10%) patients, respectively. The capacity of both drugs to prevent deep vein thrombosis was demonstrated. Compared with the control group, those who used low molecular weight heparin showed a significant increase of activated factor X inhibition and smaller increases in activated partial thromboplastin times. Tolerability of both drugs was good, with a low incidence of local side-effects.
FishermanAPKelleyMA: Pulmonary thromboembolism. In: Pulmonary Diseases and Disorders (FishermanAP, ed). New York: McGraw-Hill, 1987; chapter 66.
2.
KakkarVVMurrayWJG: Efficacy and safety of low-molecular-weight heparin (CY216) in preventing postoperative venous thromboembolism: a co-operative study. Br J Surg1985; 72: 786–791.
3.
HennyCPTen CateHTen CateJW: Use of a new heparinoid as anticoagulant during acute haemodialysis of patients with bleeding complications. Lancet1983; ii: 890–893.
4.
HennyCPTen CateHSurachnoS: The effectiveness of a low molecular weight heparinoid in chronic intermittent haemodialysis. Thromb Haemost1985; 54: 460–462.
5.
Schmitz-HuebnerURüschemeyerCSchulteH: Influence of low molecular weight heparin on the hemostatic system after abdominal surgery. Thromb Haemost1985; 53: 297–300.
6.
FareedJWalengaJMHoppenstaedtDA: Studies on the profibrinolytic actions of heparin and its fractions. Semin Thromb Hemost1985; 11: 199–207.
7.
LaurentTCTengbladAThunbergL: The molecular weight dependence of the anticoagulant activity of heparin. Biochem J1978; 175: 691–701.
8.
AnderssonLOBarrowcliffeTWHolmerE: Molecular weight dependence of the heparin potentiated inhibition of thrombin and activated factor X. Effect of heparin neutralization in plasma. Thromb Res1979; 15: 531–541.
9.
HolmerEKurachiKSöderströmG: The molecular weight dependence of the rateenhancing effect of heparin on the inhibition of factor Xa, factor IXa, factor XIa, factor XIIa and kallikrein by antithrombin. Biochem J1981; 193: 395–400.
10.
JohnsonEAMulloyB: The molecular weight range of mucosal heparin preparations. Carbohydr Res1976; 51: 119–127.
11.
CarterCJKeltonJCHirschJ: The relationship between the hemorrhagic and antithrombotic properties of low-molecular-weight heparin in rabbits. Blood1982; 59: 1239–1245.
12.
SigelBFelixWRPopkyGL: Diagnosis of lower limb venous thrombosis by Doppler ultrasound technique. Arch Surg1972; 104: 174.
13.
KakkarVVNicolaidesANRennyJTG: 125I-fibrinogen test adapted for routine screening. Lancet1970; i: 540–542.
14.
TeienANLieMAbildgaardU: Assay of heparin in plasma using a chromogenic substrate for activated factor XThromb Res1976; 8: 549–553.
GallusASHirshJO'BrienSE: Prevention of venous thrombosis with small subcutaneous doses of heparin. J Am Med Assoc1976; 235: 980–990.
17.
GallusASHirshJ: Prevention of venous thromboembolism. Sem Thromb Hemost1976; 2: 232–290.
18.
Gordon-SmithICGrundyDJLequesneLP: Controlled trial of two regimens of subcutaneous heparin in the prevention of postoperative deep vein thrombosis. Lancet1972; i: 1133–1140.
19.
MannucciPMCitterioLEPanajotapoulosN: Low dose heparin and DVT after total hip replacement. Thromb Hemost1976; 35: 157–161.
20.
MorrisGKMitchellJRA: Preventing venous thromboembolism in elderly patients with hip fracture: studies of low dose heparin, dipyridamole, aspirin and florbiprófen. Brit Med J1977; 535–537
21.
SamamaMBernardPBonnardotJP: Low molecular weight heparin compared with unfractioned heparin in prevention of postoperative thrombosis. Brit J Surg1988; 75: 128–131.
22.
CaenJP: A randomized double-blind study between a low molecular weight heparin (KABI 2165) and standard heparin in the prevention of deep vein thrombosis in general surgery. Thromb Haemost1988; 59: 216–220.
23.
CadeJFWoodMMaganiHN: Early clinical experience of a new heparinoid, ORG 10172. Thromb Res1987; 45: 497–503.
24.
KollerMSchochUBuchmannP: Low molecular weight heparin (KABI 2165) as thromboprophylaxis in elective visceral surgery. Thromb Haemost1986: 56: 243–246.
